Home | CRISPR Therapeutics
CRISPR Therapeutics is a clinical-stage gene editing company in Zug, Switzerland, founded 2013 by Emmanuelle Charpentier. CTX001 (exa-cel) approved for sickle cell and beta thalassemia.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2016
Sep 2016
Jan 2016
Apr 2015
Apr 2014
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
